English
Home > Products > CAS:58-22-0

China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • Progesterone

    Progesterone

    Progesterone has EP, USP, CP, JP, IP and KP specifications. CEP available, EU-GMP,FDA approved.

    CAS:57-83-0

  • Drospirenone

    Drospirenone

    Drospirenone has EP,USP specifications. DMF approved.

    CAS:67392-87-4

  • Eslicarbazepine Acetate

    Eslicarbazepine Acetate

    Eslicarbazepine Acetate has In-house specification. DMF approved.

    CAS:236395-14-5

  • Oseltamivir Phosphate

    Oseltamivir Phosphate

    Oseltamivir Phosphate has CP ,EP and USP specifications. DMF available.

    CAS:204255-11-8

  • Cariprazine hydrochloride

    Cariprazine hydrochloride

    Cariprazine hydrochloride has In-house specification. DMF approved.

    CAS:1083076-69-0

  • Luliconazole

    Luliconazole

    Luliconazole has In-house specification, DMF approved.

    CAS:187164-19-8

  • Related Blog
  • Reviews

  • 2024 CPhI Exhibition Shanghai

    In 2024, CPhI China will continue to be a unique opportunity for global pharmaceutical companies, manufacturers and suppliers. We will be waiting for you at the W1G20 booth on time to explore and interpret new trends in the pharmaceutical industry and interact with each other to further expand their business cooperation and various business opportunities. See you in Shanghai!

  • Gedian Humanwell successfully passed the EDQM audit

    The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

  • 2024 VIETNAM MEDI-PHARM EXPO

    VIETNAM MEDI-PHARM EXPO 2024 will be held at Saigon Exhibition & Convention Center – SECC from August 1 to 3, our booth number is I19.

  • Join Us at Booth N25 for CPHI Korea 2025 in Seoul

  • What Are The Best Practices For Creating Intermediates Category Content

    For two decades at Google, my daily focus was unraveling how users search and what content truly satisfies their intent. One of the most persistent challenges I’ve seen businesses face is effectively presenting their specialized products, especially in technical niches. This is particularly true when crafting content for an Intermediates Category.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept